Keller ET - Search Results

1

Mechanisms of Metastatic Tumor Dormancy.

Osisami M, Keller ET. Osisami M, et al. Among authors: keller et. J Clin Med. 2013 Sep 23;2(3):136-50. doi: 10.3390/jcm2030136. J Clin Med. 2013. PMID: 26237067 Free PMC article. Review.

2

SPDEF: a molecular switch for E-cadherin expression that promotes prostate cancer metastasis.

Osisami M, Keller ET. Osisami M, et al. Among authors: keller et. Asian J Androl. 2013 Sep;15(5):584-5. doi: 10.1038/aja.2013.64. Epub 2013 May 27. Asian J Androl. 2013. PMID: 23708459 Free PMC article. No abstract available.

3

Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.

Zhang M, Osisami M, Dai J, Keller JM, Escara-Wilke J, Mizokami A, Keller ET. Zhang M, et al. Among authors: keller et, keller jm. Mol Cancer Res. 2017 Apr;15(4):457-466. doi: 10.1158/1541-7786.MCR-16-0392. Epub 2017 Jan 13. Mol Cancer Res. 2017. PMID: 28087740 Free PMC article.

4

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Zhang J, et al. Among authors: keller et. J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685. J Clin Invest. 2001. PMID: 11375413 Free PMC article.

5

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Lu Y, Zhang J, Dai J, Dehne LA, Mizokami A, Yao Z, Keller ET. Lu Y, et al. Among authors: keller et. Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6. Clin Exp Metastasis. 2004. PMID: 15672864 Free article.

6

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.

Loberg RD, Logothetis CJ, Keller ET, Pienta KJ. Loberg RD, et al. Among authors: keller et. J Clin Oncol. 2005 Nov 10;23(32):8232-41. doi: 10.1200/JCO.2005.03.0841. J Clin Oncol. 2005. PMID: 16278478 Review.

7

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.

Kryczek I, Wei S, Keller E, Liu R, Zou W. Kryczek I, et al. Am J Physiol Cell Physiol. 2007 Mar;292(3):C987-95. doi: 10.1152/ajpcell.00406.2006. Epub 2006 Aug 30. Am J Physiol Cell Physiol. 2007. PMID: 16943240 Free article. Review.

8

NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.

Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY. Park BK, et al. Among authors: keller et. Nat Med. 2007 Jan;13(1):62-9. doi: 10.1038/nm1519. Epub 2006 Dec 10. Nat Med. 2007. PMID: 17159986

9

The first Tianjin, China forum on tumor microenvironment.

Keller ET, Li LY. Keller ET, et al. Cancer Res. 2011 Jan 15;71(2):310-3. doi: 10.1158/0008-5472.CAN-10-2930. Epub 2011 Jan 11. Cancer Res. 2011. PMID: 21224351 Free PMC article.

10

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.

McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR, Buckanovich RJ. McLean K, et al. J Clin Invest. 2011 Aug;121(8):3206-19. doi: 10.1172/JCI45273. J Clin Invest. 2011. PMID: 21737876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page